With Acquisition of Kite Pharma, Gilead Becomes a 'Major Player' in CAR-T Arena - InvestorIdeas.com (press release)

August 31, 2017 (Investorideas.com Newswire) Jason Kolbert, analyst with Maxim Group, assesses the billion-dollar transaction that would bring Kite Pharma and the earning potential of its cell therapy programs under the larger biotech's umbrella. In an ...

Kite Pharma's Success Is Nothing Compared to Teva's Failure - Haaretz

It's an American company, but Kite Pharmaceuticals' core technology was developed by a Weizmann Institute researcher here in Israel, and the company was founded and led by another Israeli. Between the two of them, they created a company that went from ...

Gilead's Fairy-Tale Comeback - Seeking Alpha

Finally, Gilead pulled the trigger and did some serious M&A activity by agreeing to acquire Kite Pharma for $11.9B. Gilead adds another potential blockbuster to its portfolio, which, despite a seemingly high price, brings lots of catalysts. Gilead's ...